Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025
Report Code: KNJ00103 No. of Pages: 220 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
The global vaccines market size is expected to exceed US$ 48 Billion by the year–end of 2025. “Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025” presents an in–depth assessment of the global vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the actual market situation and future outlook for the global vaccines market. The report includes historical data from 2015 to 2018 and forecasts until 2025. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global vaccines market. The report explores a detailed analysis of the top 42 vaccines market value assessment globally from 2015 to 2018 and forecasts to 2025. Additionally, the report includes an assessment of promising vaccines in clinical development by major companies. Key trends in terms of collaboration, merger & acquisitions, partnerships, distribution, exclusive and licensing agreement are analyzed with details. The report also explores the detailed description of growth drivers and inhibitors of the global vaccines market. The report concludes with the profiles of major players in the global vaccines market. The key market players are evaluated on various parameters such as business overview, vaccines portfolios, promising vaccines in the clinical development, vaccines market value analysis and recent development. Long–term Growth Projection: • Merck acquired Immune Design in 2019 • Shingrix is set to achieve blockbuster vaccine status in 2019 • Prevnar / Prevnar 13 has captured the highest market share of the global vaccines market • With a market value of more than US$ 7 billion, GSK led the global vaccines market in 2018 Top 42 Vaccines Covered Under This Report Are: 1. Prevnar / Prevnar 13 2. Gardasil / Gardasil 9 3. Vaxigrip 4. Fluzone 5. Flublok 6. Varivax 7. Menactra 8. Proquad 9. Pneumovax 23 10. Fluarix/FluLaval 11. Havrix/Twinrix/Engerix–B 12. Priorix, Priorix Tetra, Varilrix 13. M–M–R II 14. Adacel 15. Boostrix 16. Bexsero 17. Menveo 18. Cervarix 19. Trumenba 20. Shingrix 21. Pentacel, Pentaxim, Imovax, Hexaxim 22. Rotateq 23. Zostavax 24. Rotarix 25. Synflorix 26. Pediarix,Infanrix 27. Ticovac 28. Biken Ha 29. Tetrabik 30. Mearubik 31. Varicella (MTP) 32. Jebik V 33. Flumist/Fluenz 34. Bio Thrax 35. Dukoral 36. Ixiaro 37. In Live 38. HeaLive 39. BiLive 40. Anflu 41. EasySix 42. Imvamune The major companies dominating this market for its products, services, and continuous product developments are: 1. Sanofi Pasteur 2. GlaxoSmithKline (GSK) 3. Merck 4. Pfizer 5. AstraZeneca 6. Mitsubishi Tanabe Pharma 7. Emergent Biosolutions 8. Astellas Pharma Inc 9. Valneva 10. Seqirus 11. Bavarian Nordic 12. Sinovac 13. Panacea Biotec 14. Bharat Biotech 15. Serum Institute of India 16. Biological E. Limited The Latest Industry Data Included in this Report: • Global Vaccines Market Size & Analysis (2015 – 2025) • Market Share Analysis of Global Vaccines Market (%),2015 – 2025 • Global Vaccines Market Share, By Brand • Global Vaccines Market Share, By Company • Global Top 42 Vaccines Market Assessment & Opportunity (Value),2015 – 2025 • Major Companies Vaccines Market Value Analysis & Forecast • Promising Vaccines in Clinical Development by Major Companies • Detailed Vaccines Portfolio of the Major Companies • Major Deals in the Global Vaccines Market • Key Market Drivers and Inhibitors of the Global Vaccines Market • Major Companies Analysis The Report Answers the Following Questions about the Global Vaccines Market: • What is the size of the global vaccines market during 2015–2025? • What will be the revenue generated by each vaccine during the forecast period? • Which vaccine provides the highest market share? • What are the leading companies dominating the global vaccines market? What is the share of these companies in the global vaccines market? • How will the industry evolve during the forecast period 2019 – 2025? • What are the key drivers and inhibitors in the current market? • What is the key development implemented by the leading players to stand out in this market? • Who are the key players in this market space?
1. ExecutiveSummary 2. Global Vaccines Market Size & Analysis (2015 – 2025) 3. Market Share Analysis of Global Vaccines Market (%),2015 – 2025 3.1 Global Vaccines Market Share, By Brand 3.2 Global Vaccines Market Share, By Company 4. Key Drivers and Inhibitors of the Global Vaccines Market 4.1 Market Drivers 4.2 Market Inhibitors 5. Global Top 42 Vaccines Market Assessment & Opportunity (Value),2015 – 2025 5.1 Prevnar / Prevnar 13 5.2 Gardasil / Gardasil 9 5.3 Vaxigrip 5.4 Fluzone 5.5 Flublok 5.6 Varivax 5.7 Menactra 5.8 Proquad 5.9 Pneumovax 23 5.10 Fluarix/FluLaval 5.11 Havrix/Twinrix/Engerix–B 5.12 Priorix, Priorix Tetra, Varilrix 5.13 M–M–R II 5.14 Adacel 5.15 Boostrix 5.16 Bexsero 5.17 Menveo 5.18 Cervarix 5.19 Trumenba 5.20 Shingrix 5.21 Pentacel, Pentaxim, Imovax, Hexaxim 5.22 Rotateq 5.23 Zostavax 5.24 Rotarix 5.25 Synflorix 5.26 Pediarix,Infanrix 5.27 Ticovac 5.28 Biken Ha 5.29 Tetrabik 5.30 Mearubik 5.31 Varicella (MTP) 5.32 Jebik V 5.33 Flumist/Fluenz 5.34 Bio Thrax 5.35 Dukoral 5.36 Ixiaro 5.37 In Live 5.38 HeaLive 5.39 BiLive 5.40 Anflu 5.41 EasySix 5.42 Imvamune 5.43 Other Vaccines 6. Major Deals in Global Vaccines Market 6.1 Merger & Acquisitions 6.2 Collaboration Deal 6.3 Licensing Agreement 6.4 Exclusive Agreement 6.5 Distribution Agreement 6.6 Partnerships 7. Key Companies Analysis 7.1 Sanofi Pasteur 7.1.1 Business Overview 7.1.2 Vaccines Portfolio 7.1.3 Vaccines Market Value Analysis & Forecast 7.1.4 Promising Vaccines in Clinical Development 7.1.5 Recent Development 7.2 GlaxoSmithKline (GSK) 7.2.1 Business Overview 7.2.2 Vaccines Portfolio 7.2.3 Vaccines Market Value Analysis & Forecast 7.2.4 Promising Vaccines in Clinical Development 7.2.5 Recent Development 7.3 Merck 7.3.1 Business Overview 7.3.2 Vaccines Portfolio 7.3.3 Vaccines Market Value Analysis & Forecast 7.3.4 Promising Vaccines in Clinical Development 7.3.5 Recent Development 7.4 Pfizer 7.4.1 Business Overview 7.4.2 Vaccines Portfolio 7.4.3 Vaccines Market Value Analysis & Forecast 7.4.4 Promising Vaccines in Clinical Development 7.4.5 Recent Development 7.5 AstraZeneca 7.5.1 Business Overview 7.5.2 Vaccines Portfolio 7.5.3 Vaccines Market Value Analysis & Forecast 7.5.4 Recent Development 7.6 Mitsubishi Tanabe Pharma 7.6.1 Business Overview 7.6.2 Vaccines Portfolio 7.6.3 Vaccine Market Value Analysis & Forecast 7.6.4 Promising Vaccines in Clinical Development 7.6.5 Recent Development 7.7 Emergent Biosolutions 7.7.1 Business Overview 7.7.2 Vaccines Portfolio 7.7.3 Vaccine Market Value Analysis & Forecast 7.7.4 Promising Vaccines in Clinical Development 7.7.5 Recent Development 7.8 Astlellas Pharma Inc 7.8.1 Business Overview 7.8.2 Vaccines Portfolio 7.8.3 Vaccines Market Value Analysis & Forecast 7.8.4 Recent Development 7.9 Valneva 7.9.1 Business Overview 7.9.2 Vaccines Portfolio 7.9.3 Vaccines Market Value Analysis & Forecast 7.9.4 Promising Vaccines in Clinical Development 7.9.5 Recent Development 7.10 Seqirus 7.10.1 Business Overview 7.10.2 Vaccines Portfolio 7.10.3 Vaccine Market Value Analysis & Forecast 7.10.4 Promising Vaccines in Clinical Development 7.10.5 Recent Development 7.11 Bavarian Nordic 7.11.1 Business Overview 7.11.2 Vaccines Portfolio 7.11.3 Vaccine Market Value Analysis & Forecast 7.11.4 Promising Vaccines in Clinical Development 7.11.5 Recent Development 7.12 Sinovac 7.12.1 Business Overview 7.12.2 Vaccines Portfolio 7.12.3 Vaccine Market Value Analysis & Forecast 7.12.4 Promising Vaccines in Clinical Development 7.12.5 Recent Development 7.13 Panacea Biotec 7.13.1 Business Overview 7.13.2 Vaccines Portfolio 7.13.3 Vaccine Market Value Analysis & Forecast 7.13.4 Promising Vaccines in Clinical Development 7.13.5 Recent Development 7.14 Bharat Biotech 7.14.1 Business Overview 7.14.2 Vaccines Portfolio 7.14.3 Promising Vaccines in Clinical Development 7.14.4 Recent Development 7.15 Serum Institute of India 7.15.1 Business Overview 7.15.2 Vaccines Portfolio 7.15.3 Promising Vaccines in Clinical Development 7.15.4 Recent Development 7.16 Biological E. Limited 7.16.1 Business Overview 7.16.2 Vaccines Portfolio 7.16.3 Promising Vaccines in Clinical Development 7.16.4 Recent Development List of Tables Table 3–1: Global Vaccines Market Share & Y–o–Y Growth By Brand (Percent), 2015 – 2018 Table 3–2: Global Vaccines Market Share & Y–o–Y Growth By Brand Forecast (Percent), 2019 – 2025 Table 3–3: Global Vaccines Market Share & Y–o–Y Growth By Company Forecast (Percent), 2015 – 2018 Table 3–4: Global Vaccines Market Share & Y–o–Y Growth By Company Forecast (Percent), 2019 – 2025 Table 6–1: Merger & Acquisitions in the Global Vaccines Market Table 6–2: Collaboration Deal in the Global Vaccines Market Table 6–3: Licensing Agreement in the Global Vaccines Market Table 6–4: Exclusive Agreement in the Global Vaccines Market Table 6–5: Distribution Agreement in the Global Vaccines Market Table 6–6: Partnerships in the Global Vaccines Market Table 7–1: Sanofi Promising Vaccines in Clinical Development Table 7–2: GSK Promising Vaccines in Clinical Development Table 7–3: Merck Promising Vaccines in Clinical Development Table 7–4: Pfizer Promising Vaccines in Clinical Development Table 7–5: Mitsubishi Tanabe Pharma Promising Vaccines in Clinical Development Table 7–6: Emergent Biosolutions Promising Vaccines in Clinical Development Table 7–7: Valneva Promising Vaccines in Clinical Development Table 7–8: Seqirus Promising Vaccines in Clinical Development Table 7–9: Bavarian Nordic Promising Vaccines in Clinical Development Table 7–10: Sinovac Promising Vaccines in Clinical Development Table 7–11: Panacea Biotec Promising Vaccines in Clinical Development Table 7–12: Bharat Biotech Promising Vaccines in Clinical Development List of Figures Figure 2–1: Global Vaccines Market Size (Million US$),2015 – 2018 Figure 2–2: Global Vaccines Market Size Forecast (Million US$),2019 – 2025 Figure 5–1: Global Prevnar/Prevnar 13 Market Value (Million US$),2015 – 2018 Figure 5–2: Global Prevnar/Prevnar 13 Market Value Forecast (Million US$),2019 – 2025 Figure 5–3: Global Gardasil/Gardasil 9 Market Value (Million US$),2015 – 2018 Figure 5–4: Global Gardasil/Gardasil 9 Market Value Forecast (Million US$),2019 – 2025 Figure 5–5: Global Vaxigrip Market Value (Million US$),2015 – 2018 Figure 5–6: Global Vaxigrip Market Value Forecast (Million US$),2019 – 2025 Figure 5–7: Global Fluzone Market Value (Million US$),2015 – 2018 Figure 5–8: Global Fluzone Market Value Forecast (Million US$),2019 – 2025 Figure 5–9: Global Flublok Market Value & Forecast (Million US$),2018 – 2025 Figure 5–10: Global Varivax Market Value (Million US$),2015 – 2018 Figure 5–11: Global Varivax Market Value Forecast (Million US$),2019 – 2025 Figure 5–12: Global Menactra Market Value (Million US$),2015 – 2018 Figure 5–13: Global Menactra Market Value Forecast (Million US$),2019 – 2025 Figure 5–14: Global Proquad Market Value (Million US$),2015 – 2018 Figure 5–15: Global Proquad Market Value Forecast (Million US$),2019 – 2025 Figure 5–16: Global Pneumovax 23 Market Value (Million US$),2015 – 2018 Figure 5–17: Global Pneumovax 23 Market Value Forecast (Million US$),2019 – 2025 Figure 5–18: Global Fluarix/FluLaval Market Value (Million US$),2015 – 2018 Figure 5–19: Global Fluarix/FluLaval Market Value Forecast (Million US$),2019 – 2025 Figure 5–20: Global Havrix/Twinrix/Engerix–B Market Value (Million US$),2015 – 2018 Figure 5–21: Global Havrix/Twinrix/Engerix–B Market Value Forecast (Million US$),2019 – 2025 Figure 5–22: Global Priorix, Priorix Tetra, Varilrix Market Value (Million US$),2015 – 2018 Figure 5–23: Global Priorix, Priorix Tetra, Varilrix Market Value Forecast (Million US$),2019 – 2025 Figure 5–24: Global M–M–R ll Market Value (Million US$),2015 – 2018 Figure 5–25: Global M–M–R ll Market Value Forecast (Million US$),2019 – 2025 Figure 5–26: Global Adacel Market Value (Million US$),2015 – 2017 Figure 5–27: Global Adacel Market Value Forecast (Million US$),2018 – 2025 Figure 5–28: Global Boostrix Market Value (Million US$),2015 – 2018 Figure 5–29: Global Boostrix Market Value Forecast (Million US$),2019 – 2025 Figure 5–30: Global Bexsero Market Value (Million US$),2015 – 2018 Figure 5–31: Global Bexsero Market Value Forecast (Million US$),2019 – 2025 Figure 5–32: Global Menveo Market Value (Million US$),2015 – 2018 Figure 5–33: Global Menveo Market Value Forecast (Million US$),2019 – 2025 Figure 5–34: Global Cervarix Market Value (Million US$),2015 – 2018 Figure 5–35: Global Cervarix Market Value Forecast (Million US$),2019 – 2025 Figure 5–36: Global Trumenba Market Value (Million US$),2015 – 2018 Figure 5–37: Global Trumenba Market Value Forecast (Million US$),2019 – 2025 Figure 5–38: Global Shingrix Market Value & Forecast (Million US$),2017 – 2018 Figure 5–39: Global Shingrix Market Value & Forecast (Million US$),2019 – 2025 Figure 5–40: Global Pentacel, Pentaxim, Imovax, Hexaxim Market Value (Million US$),2015 – 2018 Figure 5–41: Global Pentacel, Pentaxim, Imovax, Hexaxim Market Value Forecast (Million US$),2018 – 2025 Figure 5–42: Global Rotateq Market Value (Million US$),2015 – 2018 Figure 5–43: Global Rotateq Market Value Forecast (Million US$),2019 – 2025 Figure 5–44: Global Zostavax Market Value (Million US$),2015 – 2018 Figure 5–45: Global Zostavax Market Value Forecast (Million US$),2019 – 2025 Figure 5–46: Global Rotarix Market Value (Million US$),2015 – 2018 Figure 5–47: Global Rotarix Market Value Forecast (Million US$),2019 – 2025 Figure 5–48: Global Synflorix Market Value (Million US$),2015 – 2018 Figure 5–49: Global Synflorix Market Value Forecast (Million US$),2019 – 2025 Figure 5–50: Global Pediarix/Infanrix Market Value (Million US$),2015 – 2018 Figure 5–51: Global Pediarix/Infanrix Market Value Forecast (Million US$),2019 – 2025 Figure 5–52: Global Ticovac Market Value (Million US$),2015 – 2018 Figure 5–53: Global Ticovac Market Value Forecast (Million US$),2019 – 2025 Figure 5–54: Global Biken Ha Market Value (Million US$),2015 – 2018 Figure 5–55: Global Biken Ha Market Value Forecast (Million US$),2019 – 2025 Figure 5–56: Global Tetrabik Market Value (Million US$),2015 – 2018 Figure 5–57: Global Tetrabik Market Value Forecast (Million US$),2019 – 2025 Figure 5–58: Global Mearubik Market Value (Million US$),2015 – 2018 Figure 5–59: Global Mearubik Market Value Forecast (Million US$),2019 – 2025 Figure 5–60: Global Varicella (MTP) Market Value (Million US$),2015 – 2018 Figure 5–61: Global Varicella (MTP) Market Value Forecast (Million US$),2019 – 2025 Figure 5–62: Global Jebik V Market Value (Million US$),2015 – 2018 Figure 5–63: Global Jebik V Market Value Forecast (Million US$),2019 – 2025 Figure 5–64: Global Flumist/Fluenz Market Value (Million US$),2015 – 2018 Figure 5–65: Global Flumist/Fluenz Market Value Forecast (Million US$),2019 – 2025 Figure 5–66: Global Bio Thrax Market Value (Million US$),2015 – 2018 Figure 5–67: Global Bio Thrax Market Value Forecast (Million US$),2019 – 2025 Figure 5–68: Global Dukoral Market Value (Million US$),2015 – 2018 Figure 5–69: Global Dukoral Market Value Forecast (Million US$),2019 – 2025 Figure 5–70: Global Ixiaro Market Value (Million US$),2015 – 2018 Figure 5–71: Global Ixiaro Market Value Forecast (Million US$),2019 – 2025 Figure 5–72: Global In Live Market Value (Million US$),2015 – 2018 Figure 5–73: Global In Live Market Value Forecast (Million US$),2019 – 2025 Figure 5–74: Global HeaLive Market Value (Million US$),2015 – 2018 Figure 5–75: Global HeaLive Market Value Forecast (Million US$),2019 – 2025 Figure 5–76: Global BiLive Market Value (Million US$),2015 – 2018 Figure 5–77: Global BiLive Market Value Forecast (Million US$),2019 – 2025 Figure 5–78: Global Anflu Market Value (Million US$),2015 – 2018 Figure 5–79: Global Anflu Market Value Forecast (Million US$),2019 – 2025 Figure 5–80: Global EasySix Market Value (Million US$),2015 – 2018 Figure 5–81: Global EasySix Market Value Forecast (Million US$),2019 – 2025 Figure 5–82: Global Imvamune Market Value (Million US$),2015 – 2018 Figure 5–83: Global Imvamune Market Value Forecast (Million US$),2019 – 2025 Figure 5–84: Global Other Vaccines Market Value (Million US$),2015 – 2018 Figure 5–85: Global Other Vaccines Market Value Forecast (Million US$),2019 – 2025 Figure 7–1: Sanofi Pasteur Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 7–2: Sanofi Pasteur Vaccines Market Value Analysis (Million US$),2019 – 2025 Figure 7–3: GSK Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 7–4: GSK Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 7–5: Merck Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 7–6: Merck Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 7–7: Pfizer Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 7–8: Pfizer Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 7–9: AstraZeneca Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 7–10: AstraZeneca Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 7–11: Mitsubishi Tanabe Pharma Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 7–12: Mitsubishi Tanabe Pharma Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 7–13: Emergent Biosolutions Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 7–14: Emergent Biosolutions Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 7–15: Astlellas Pharma Inc Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 7–16: Astlellas Pharma Inc Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 7–17: Valneva Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 7–18: Valneva Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 7–19: Seqirus Vaccines Market Value Analysis (Million US$),2016 – 2018 Figure 7–20: Seqirus Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 7–21: Bavarian Nordic Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 7–22: Bavarian Nordic Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 7–23: Sinovac Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 7–24: Sinovac Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025 Figure 7–25: Panacea Biotec Vaccines Market Value Analysis (Million US$),2015 – 2018 Figure 7–26: Panacea Biotec Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com